Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).

NCT04225325 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

112

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

COMBINATION_PRODUCT: SYMTUZA
COMBINATION_PRODUCT: DESCOVY+DOLUTEGRAVIR
COMBINATION_PRODUCT: SYMTUZA+DOLUTEGRAVIR

Sponsor

ADRIANO LAZZARIN, MD

Collaborators

[object Object]